Status:
COMPLETED
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
American College of Medical Toxicology
Blue Cross Blue Shield
Conditions:
Opioid Use
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study seeks to test standard and behavioral economic-enhanced training strategies to bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among Emergency Depart...
Detailed Description
Philadelphia is experiencing a significant opioid crisis. Through this novel pilot study, critical training about opioid use disorder and medication-assisted treatment with buprenorphine-naloxone will...
Eligibility Criteria
Inclusion
- Residents and Advanced Practice Providers and attending clinicians working in emergency departments in Pennsylvania.
Exclusion
- \-
Key Trial Info
Start Date :
February 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03821103
Start Date
February 6 2019
End Date
February 29 2020
Last Update
March 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States, 19104